The Zhitong Finance App learned that recently, J.P. Morgan Chase released a US stock research report on Nike (NKE.US). The research team participated in a face-to-face meeting with Nike's new CFO Denton, maintaining Nike's “Underweight (Underweight)” investment rating in conjunction with management statements to update profit assumptions. The target price remained at 33 US dollars in December 2027. The report warns that due to the influence of the Jordan brand and the strategic reshaping of the Greater China region, the company's performance pain cycle may be extended to fiscal year 2028.
Zhitongcaijing · 3d ago
Share
Listen to the news
The Zhitong Finance App learned that recently, J.P. Morgan Chase released a US stock research report on Nike (NKE.US). The research team participated in a face-to-face meeting with Nike's new CFO Denton, maintaining Nike's “Underweight (Underweight)” investment rating in conjunction with management statements to update profit assumptions. The target price remained at 33 US dollars in December 2027. The report warns that due to the influence of the Jordan brand and the strategic reshaping of the Greater China region, the company's performance pain cycle may be extended to fiscal year 2028.
Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.
What's Trending